🇺🇸 FDA
Pipeline program

Brincidofovir

CMX001-211

Phase 2 small_molecule terminated

Quick answer

Brincidofovir for Adenovirus is a Phase 2 program (small_molecule) at Jazz Pharmaceuticals plc with 2 ClinicalTrials.gov record(s).

Program details

Company
Jazz Pharmaceuticals plc
Indication
Adenovirus
Phase
Phase 2
Modality
small_molecule
Status
terminated

Clinical trials